Healthcare
Live Price
Offline$63.16
+0.98% today
1Y Change
+55.57%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 250 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Tarsus Pharmaceuticals, Inc. (TARS) is a Healthcare stock with a market cap of $2.71B and listed on NASDAQ. The stock last traded around $63.16 and up 55.6% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +146.7%, EPS growth of +48.2%, a dividend yield of 0.0%. What stands out right now is revenue +146.7%, EPS +48.2%, free cash flow +73.6% with operating margin -15.7% and ROIC -16.6%. Valuation sits in the middle of the pack at price/sales 6.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines TARS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TARS
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TARS Max Drawdown
-30.42%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TARS and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.